Will the end result of Tuesday’s U.S. presidential election will bring more or less stability to both the United States and global game plan?
If you are not happy with the results below please do another search
50 search results for:
Johnson & Johnson plans to start testing the company’s experimental Covid-19 vaccine in youths aged 12 to 18 as soon as possible, a company executive said at a meeting held by the U.S. Centers for Disease Control and Prevention (CDC).
AbCellera and Kodiak Sciences announced a new partnership to create and develop therapeutic antibodies for ophthalmologic indications.
Shares of Bellicum Pharmaceuticals plunged following an announcement that the company will slash 79% of employees as part of a restructuring following the developmental pause for one CAR-T program.
Regeneron Pharmaceuticals will stop enrolling patients receiving advanced Covid-19 care in a trial testing the company’s experimental antibody treatment in hospitalized patients, based on the recommendation of an independent safety board.
Walmart Inc. unit Sam’s Club said the warehouse chain will provide prescribed medicines to patients through delivery firm DoorDash Inc., as customers turn to digital orders during the Covid-19 pandemic.
A record surge of coronavirus cases in the United States is pushing hospitals to the brink of capacity and killing up to 1,000 people a day, the latest figures show, with much of the country’s attention focused on the 2020 presidential election.
AstraZeneca Plc will sell commercial rights for two products to a German pharmaceutical company for $400 million as the British drugmaker looks to focus on newer medicines in new therapy areas.
Syneos Health announced an agreement to acquire Synteract, a full-service contract research organization (CRO) focused on the biopharmaceutical industry.
The European Commission approved Novartis’ Adakveo (crizanlizumab) for the prevention of recurrent vaso-occlusive crises (VOCs), or pain crises, in patients with sickle cell disease aged 16 years and older.